October 29, 2010
The common shares of Premier Diagnostic Health Services Inc. have been approved for listing on CNSX. The Company has 32,663,313 shares outstanding with a public float of approximately 20.5 million shares.
Premier Diagnostics provides advanced nuclear medicine diagnostic imaging services using positron emission tomography/ x-ray computed tomography (“PET/CT”) scan for the early detection of cancer, heart, and brain diseases. The Company intends to establish centres for advanced diagnostic imaging, together with an integrated support services infrastructure, utilizing PET (positron emission tomography) scanning technology. PET is used in the early detection, evaluation and management of cancer and also in the evaluation of heart disease and Alzheimer’s disease.
Listing and disclosure documents for Premier Diagnostic Health Services Inc. will be available in the CNSX Listings Disclosure Hall
Trading Date: Monday, November 1, 2010
CUSIP: 74049T 10 4
ISIN: CA 74049T 10 4 9
Applications are being accepted for Market Makers for "PDH". If you have any questions or require further information please contact Radhika at (416) 572-2000 X 2435 or E-mail: email@example.com